Call for Evidence
The Science and Technology Select Committee has set
up Sub-Committee I, with Lord Soulsby of Swaffham Prior in the
chair, to consider and report on issues relating to human infectious
disease in the United Kingdom, including
effectiveness of the surveillance systems in the United Kingdom
and potential problems in the future
between surveillance and treatment of infectious disease
between surveillance and the strategies for preventing infectious
and to pay regard to
in surveillance, vaccine and diagnostic technologies
approaches to surveillance, treatment and prevention of infectious
attitudes, risk-perception and the role of the media.
We invite written submissions by 14th October 2002,
which are relevant to our terms of reference, and addressed in
particular to the following questions:
1. What are the main problems facing the
surveillance, treatment and prevention of human infectious disease
in the United Kingdom?
2. Will these problems be adequately addressed
by the Government's recent infectious disease strategy, Getting
Ahead of the Curve?
3. Is the United Kingdom benefiting from
advances in surveillance and diagnostic technologies; if not,
what are the obstacles to its doing so?
4. Should the United Kingdom make greater
use of vaccines to combat infection and what problems exist for
developing new, more effective or safer vaccines?
5. Which infectious diseases pose the biggest
threats in the foreseeable future?
6. What policy interventions would have
the greatest impact on preventing outbreaks of and damage caused
by infectious disease in the United Kingdom?
The Committee welcomes evidence on any area of infectious
disease. However, as other bodies have recently inquired, or are
in the process of inquiring into antimicrobial resistance, hospital-acquired
infections and sexually transmitted infection, the Committee will
not make these primary concerns in its inquiry. Nevertheless the
Committee will not exclude these areas.
Please note that the Committee will focus on UK health
issues, not diseases primarily affecting overseas countries, whilst
acknowledging that infection crosses borders and may threaten
the United Kingdom. The Committee will also focus on naturally
occurring infection rather than bioterrorism.
The Committee will not consider evidence on whether
the MMR vaccine is safe.